CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target

BACKGROUND: Liver hepatocellular carcinoma (LIHC) is one of the malignant tumors with high incidence as well as high death, which is ranked as the sixth most common tumor and the third highest mortality worldwide. CD93, a transmembrane protein, has been widely reported to play an important role in d...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Qianwei, Kuai, Jing, Jiang, Zhongyi, Que, Weitao, Wang, Pusen, Huang, Wenxin, Ding, Wei, Zhong, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359974/
https://www.ncbi.nlm.nih.gov/pubmed/37483608
http://dx.doi.org/10.3389/fimmu.2023.1158360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359974/
https://www.ncbi.nlm.nih.gov/pubmed/37483608
http://dx.doi.org/10.3389/fimmu.2023.1158360

Ejemplares similares